Does ELOSULFASE ALFA Cause Mobility decreased? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Mobility decreased have been filed in association with ELOSULFASE ALFA (VIMIZIM). This represents 0.7% of all adverse event reports for ELOSULFASE ALFA.
36
Reports of Mobility decreased with ELOSULFASE ALFA
0.7%
of all ELOSULFASE ALFA reports
0
Deaths
11
Hospitalizations
How Dangerous Is Mobility decreased From ELOSULFASE ALFA?
Of the 36 reports, 11 (30.6%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELOSULFASE ALFA. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does ELOSULFASE ALFA Cause?
Pyrexia (682)
Cough (318)
Vomiting (308)
Malaise (282)
Headache (242)
Dyspnoea (216)
Nausea (212)
Pain (205)
Nasopharyngitis (183)
Fatigue (177)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ELOSULFASE ALFA Alternatives Have Lower Mobility decreased Risk?
ELOSULFASE ALFA vs ELOTUZUMAB
ELOSULFASE ALFA vs ELOXATIN
ELOSULFASE ALFA vs ELRANATAMAB
ELOSULFASE ALFA vs ELRANATAMAB-BCMM
ELOSULFASE ALFA vs ELTROMBOPAG